BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmirotta R, Carella C, Silvestris E, Cives M, Stucci SL, Tucci M, Lovero D, Silvestris F. SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand. Oncotarget 2018;9:25355-82. [PMID: 29861877 DOI: 10.18632/oncotarget.25256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Varma A, Mathaiyan J, Shewade D, Dubashi B, Sunitha K. Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India. J Clin Pharm Ther 2020;45:617-27. [PMID: 32399998 DOI: 10.1111/jcpt.13166] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Very N, Hardivillé S, Decourcelle A, Thévenet J, Djouina M, Page A, Vergoten G, Schulz C, Kerr-Conte J, Lefebvre T, Dehennaut V, El Yazidi-Belkoura I. Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer. Oncogene 2021. [PMID: 34845374 DOI: 10.1038/s41388-021-02121-9] [Reference Citation Analysis]
3 Botton MR, Hentschke-Lopes M, Matte U. Frequency of DPYD gene variants and phenotype inference in a Southern Brazilian population. Ann Hum Genet 2021. [PMID: 34897655 DOI: 10.1111/ahg.12453] [Reference Citation Analysis]
4 Allahloubi NMA, Zekri AN, Ragab M, Mohanad M, Ahmed OS, Eid S, Ghareeb M, Gouda I, Bahnassy AA. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochem Genet 2022. [PMID: 35182276 DOI: 10.1007/s10528-022-10199-3] [Reference Citation Analysis]
5 Mbah Ntepe LJ, Habib R, Judith Laure N, Raza S, Nepovimova E, Kuca K, Batool S, Muhammad Nurulain S. Oxidative Stress and Analysis of Selected SNPs of ACHE (rs 2571598), BCHE (rs 3495), CAT (rs 7943316), SIRT1 (rs 10823108), GSTP1 (rs 1695), and Gene GSTM1, GSTT1 in Chronic Organophosphates Exposed Groups from Cameroon and Pakistan. Int J Mol Sci 2020;21:E6432. [PMID: 32899431 DOI: 10.3390/ijms21176432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Roberto M, Rossi A, Panebianco M, Pomes LM, Arrivi G, Ierinò D, Simmaco M, Marchetti P, Mazzuca F. Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach. Pharmaceuticals (Basel) 2021;14:67. [PMID: 33467633 DOI: 10.3390/ph14010067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Mani RS, Mermershtain I, Abdou I, Fanta M, Hendzel MJ, Glover JNM, Weinfeld M. Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1. J Biol Chem 2019;294:520-30. [PMID: 30446622 DOI: 10.1074/jbc.RA118.004262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Fonnesbech Hjorth C, Damkier P, Bjerregaard Stage T, Feddersen S, Hamilton-Dutoit S, Rørth M, Ejlertsen B, Lee Lash T, Patrick Ahern T, Toft Sørensen H, Cronin-Fenton D. Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast Cancer Res Treat 2022. [PMID: 35501422 DOI: 10.1007/s10549-022-06596-2] [Reference Citation Analysis]
9 Albitar L, Alchamat GA. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians. BMC Health Serv Res 2021;21:1031. [PMID: 34592972 DOI: 10.1186/s12913-021-07040-9] [Reference Citation Analysis]
10 Palmirotta R, Lovero D, Delacour H, Le Roy A, Cremades S, Silvestris F. Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report. Front Oncol 2019;9:139. [PMID: 30915274 DOI: 10.3389/fonc.2019.00139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 De Mattia E, Polesel J, Roncato R, Labriet A, Bignucolo A, Gagno S, Buonadonna A, D'Andrea M, Lévesque E, Jonker D, Couture F, Guillemette C, Cecchin E, Toffoli G. IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm. Cancers (Basel) 2021;13:1705. [PMID: 33916844 DOI: 10.3390/cancers13071705] [Reference Citation Analysis]
12 Spasić J, Radosavljević D, Nagorni-obradović L. The influence of genetic polymorphisms on the toxicity of platinum-based chemotherapy in the treatment of non-small cell lung cancer. Medicinski podmladak 2021;72:40-7. [DOI: 10.5937/mp72-31940] [Reference Citation Analysis]
13 Tryggvadottir H, Huzell L, Gustbée E, Simonsson M, Markkula A, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H. Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients. Front Oncol 2018;8:428. [PMID: 30370250 DOI: 10.3389/fonc.2018.00428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu Y, Ali S, White RJ. Use of Electrocatalysis for Differentiating DNA Polymorphisms and Enhancing the Sensitivity of Electrochemical Nucleic Acid-Based Sensors with Covalent Redox Tags-Part II. ACS Sens 2020;5:3842-9. [PMID: 33305566 DOI: 10.1021/acssensors.0c02363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Osman N, Shawky AE, Brylinski M. Exploring the effects of genetic variation on gene regulation in cancer in the context of 3D genome structure. BMC Genom Data 2022;23:13. [PMID: 35176995 DOI: 10.1186/s12863-021-01021-x] [Reference Citation Analysis]
16 Silvestris E, Lovero D, Palmirotta R. Nutrition and Female Fertility: An Interdependent Correlation. Front Endocrinol (Lausanne) 2019;10:346. [PMID: 31231310 DOI: 10.3389/fendo.2019.00346] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
17 Panebianco M, Taurelli Salimbeni B, Roberto M, Marchetti P. An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report). Curr Oncol 2021;28:1980-7. [PMID: 34070464 DOI: 10.3390/curroncol28030184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cordova-Delgado M, Bravo ML, Cumsille E, Hill CN, Muñoz-Medel M, Pinto MP, Retamal IN, Lavanderos MA, Miquel JF, Rodriguez-Fernandez M, Liao Y, Li Z, Corvalán AH, Armisén R, Garrido M, Quiñones LA, Owen GI. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. BMC Cancer 2021;21:1030. [PMID: 34525956 DOI: 10.1186/s12885-021-08745-0] [Reference Citation Analysis]